Altimmune, Inc

(NASDAQ:ALT)

Latest On Altimmune, Inc (ALT):

Date/Time Type Description Signal Details
2023-05-11 16:23 ESTNewsAltimmune GAAP EPS of -$0.40 beats by $0.08N/A
2023-05-11 16:22 ESTNewsAltimmune, Inc. (ALT) Q1 2023 Earnings Call TranscriptN/A
2023-05-10 12:33 ESTNewsAltimmune: A Story, It Seems, Of Too Little Too LateN/A
2023-03-22 23:18 ESTNewsAltimmune hits 10-month low as Goldman Sachs downgrades on weight loss dataN/A
2023-03-21 16:21 ESTNewsAltimmune stock slumps ~35% amid phase 2 trial data of obesity drug pemvidutideN/A
2023-03-21 16:20 ESTNewsAltimmune leads obesity drug developers lower after data for lead assetN/A
2023-02-28 16:09 ESTNewsAltimmune GAAP EPS of -$0.43 beats by $0.11N/A
2023-02-28 16:07 ESTNewsAltimmune (ALT) Q4 2022 Earnings Call TranscriptN/A
2023-02-28 01:16 ESTNewsAltimmune Q4 2022 Earnings PreviewN/A
2023-02-23 11:31 ESTNewsAltimmune's Peptide-Based Therapies Offer Substantial OpportunityN/A
2023-02-21 21:15 ESTNewsAltimmune: Potential Dual Action For Pemvidutide In Obesity, NASHN/A
2022-12-21 01:07 ESTNewsAltimmune rises 5% on positive data from phase 1 trial of Non-Alcoholic Fatty Liver Disease treatmentN/A
2022-12-02 18:36 ESTNewsAltimmune Appears To Have A Winner, But Will The Market Believe?N/A
2022-12-02 01:08 ESTNewsAltimmune spikes as Goldman Sachs sees over 100% upsideN/A
2022-11-30 13:10 ESTNewsAltimmune: Weight Loss Data Signals A Costly ConfusionN/A
2022-11-11 05:50 ESTNewsAltimmune, Inc. (ALT) Q3 2022 Earnings Call TranscriptN/A
2022-11-10 12:39 ESTNewsAltimmune GAAP EPS of -$0.48 beats by $0.01N/A
2022-11-10 12:38 ESTNewsAltimmune rises 5.2% on smaller-than-expected Q3 lossN/A
2022-09-16 22:56 ESTNewsAltimmune defended at H.C. Wainwright ahead of key readout for obesity drugN/A
2022-09-15 11:25 ESTNewsAltimmune: Overreaction On NASH Data Creates Buying OpportunityN/A
2022-09-14 18:07 ESTNewsAltimmune stock slumps 56% despite drug meeting main goal of reducing liver fat in trialN/A
2022-09-14 18:07 ESTNewsPiper Sandler sees Altimmune liver/obesity drug competitive despite weight loss dataN/A
2022-09-07 13:52 ESTNewsReassessing AltimmuneN/A
2022-09-01 01:36 ESTNewsAltimmune sets new 52-week high on rising volumeN/A
2022-08-11 22:36 ESTNewsAltimmune GAAP EPS of -$0.42 beats by $0.05, revenue of $8KN/A
2022-08-11 22:36 ESTNewsAltimmune quarterly net loss narrows as it beats on the bottom lineN/A
2022-08-11 22:36 ESTNewsAltimmune, Inc. (ALT) CEO Vipin Garg on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-11 05:48 ESTNewsAltimmune Q2 2022 Earnings PreviewN/A
2022-06-29 11:28 ESTNewsAltimmune: Several Catalysts In 2 Large Market Indications This YearN/A
2022-05-13 06:49 ESTNewsAltimmune, Inc. (ALT) CEO Vipin K. Garg on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-12 12:17 ESTNewsAltimmune GAAP EPS of -$0.44 beats by $0.14, revenue of $0.03M misses by $0.85MN/A
2022-05-11 18:31 ESTNewsAltimmune Q1 2022 Earnings PreviewN/A
2022-04-07 19:53 ESTNewsAltimmune's New Avatar As A Liver Disease PlayerN/A
2022-04-01 18:50 ESTNewsAltimmune begins enrollment in phase 2 trial of pemvidutide to treat obesityN/A
2022-03-15 16:28 ESTNewsAltimmune GAAP EPS of -$0.57 beats by $0.08, revenue of $3.28M beats by $3.19MN/A
2022-03-15 16:28 ESTNewsAltimmune stock falls ~5% despite Q4 beatN/A
2022-03-15 16:28 ESTNewsAltimmune, Inc. (ALT) CEO Vipin Garg on Q4 2021 Results - Earnings Call TranscriptN/A
2022-01-31 13:06 ESTNewsFDA clears Altimmune's pemvidutide application for obesityN/A
2022-01-03 16:07 ESTNewsAltimmune: Changing Focus To Pemvidutide In 2022N/A
2021-12-13 14:56 ESTNewsNew finance chief at AltimmuneN/A
2021-11-23 16:46 ESTNewsWarning: ALT is at high risk of performing badlyN/A
2021-11-22 18:32 ESTNewsAltimmune (ALT) Presents At 2021 Virtual Healthcare Conference - SlideshowN/A
2021-11-11 20:59 ESTNewsAltimmune, Inc.'s (ALT) CEO Vipin Garg on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-11 00:44 ESTNewsAltimmune EPS misses by $0.38, beats on revenueN/A
2021-11-11 00:43 ESTNewsAltimmune, Inc. (ALT) CEO Vipin Garg on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-10 02:01 ESTNewsAltimmune Q3 2021 Earnings PreviewN/A
2021-10-16 20:22 ESTNewsAltimmune: Changing The ThesisN/A
2021-10-04 22:54 ESTNewsAltimmune initiates Phase 1b trial of pemvidutide in non-alcoholic fatty liver diseaseN/A
2021-09-28 11:25 ESTNewsAltimmune spikes on data readout for obesity therapy tomorrowN/A
2021-09-28 11:25 ESTNewsAltimmune slips after posting 12-week data from Phase 1 trial for weight loss therapyN/A

About Altimmune, Inc (ALT):

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing intranasal vaccines, immune modulating therapies, and treatments for liver disease. The company develops AdCOVID, a single-dose intranasal vaccine that is in Phase I clinical trial to protect against COVID-19; T-COVID, an intranasal immune modulating therapeutic candidate, which is in Phase I/II clinical trial to evaluate the potential of T-COVID to prevent clinical worsening in patients with early COVID-19; NasoShield, an anthrax vaccine product candidate that is in a Phase 1b trial; and NasoVAX, a recombinant intranasal vaccine product candidate, which completed Phase IIa clinical trial for the treatment of seasonal and pandemic use. It also focuses on developing ALT-801, a novel peptide-based dual GLP-1/glucagon receptor agonist for the treatment of non-alcoholic steatohepatitis that is in Phase I clinical trial; and HepTcell, an immunotherapeutic product candidate, which is in Phase II clinical trial for patients chronically infected with the hepatitis B virus. Altimmune, Inc. has a collaboration with the University of Alabama at Birmingham for the development of AdCOVID. The company is headquartered in Gaithersburg, Maryland.

ALT Quotes by TradingView

See Advanced Chart

General

  • Name Altimmune, Inc
  • Symbol ALT
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 43
  • Last Split Factor1:30
  • Last Split Date2018-09-14
  • Fiscal Year EndDecember
  • IPO Date2005-10-06
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://altimmune.com
View More

Valuation

  • Trailing PE 1.82
  • Price/Sales (Trailing 12 Mt.) 54.44
  • Price/Book (Most Recent Quarter) 2.86
  • Enterprise Value Revenue 52.73
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.04
  • Next Year EPS Estimate $0.70
  • Next Quarter EPS Estimate -$0.18
  • Operating Margin -471%
  • Return on Assets -16%
  • Return on Equity -36%
  • Revenue 8.19 million
  • Earnings Per Share -$4.16
  • Revenue Per Share $0.32
  • Gross Profit -25324291
  • Quarterly Earnings Growth 301.7%
View More

Highlights

  • Market Capitalization 641.59 million
  • EBITDA -11790191
  • Analyst Target Price $41.83
  • Book Value Per Share $6.11
View More

Share Statistics

  • Shares Outstanding 37.15 million
  • Shares Float 29.2 million
  • % Held by Insiders 651%
  • % Held by Institutions 67.3%
  • Shares Short 2.41 million
  • Shares Short Prior Month 2.52 million
  • Short Ratio 1.22
  • Short % of Float 8%
  • Short % of Shares Outstanding 7%
View More

Technicals

  • Beta 1.37
  • 52 Week High $35.1
  • 52 Week Low $2.68
  • 50 Day Moving Average 17.82
  • 200 Day Moving Average 13.78
View More

Dividends

  • Dividend Date 2018-09-14
  • ExDividend Date 2017-01-20
  • Dividend Yield 0%
View More

Altimmune, Inc (ALT) Dividend Calendar:

ALT's last dividend payment was made to shareholders on September 14, 2018.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Altimmune, Inc (ALT) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$2.31 million-$0.17-$0.8078.84%
2020-09-302020-11-09$2.94 million-$0.54-$0.7628.95%
2020-06-302020-08-11$N/A-$0.94-$0.29-229.82%
2020-03-312020-05-13$2.21 million-$0.26-$0.3218.75%
2019-12-312020-03-27$N/A-$0.25-$0.263.85%
2019-09-302019-11-13$643978-$0.74-$0.19-289.47%
2019-06-302019-08-13$1.63 million-$0.26-$0.25-4%
2019-03-312019-04-01$2.96 million-$0.27-$2.8090.36%
2018-12-312019-03-31$2.59 million-$2.34-$2.8016.43%
2018-09-302018-11-13$2.63 million-$1.73-$3.6051.94%
2018-06-302018-08-14$2.42 million-$10.20-$4.50-126.67%
2018-03-312018-05-15$2.69 million-$8.73-$15.0041.78%
2017-12-312018-03-28$2.3 million-$2.40-$15.0084%
2017-09-302017-11-09$4.59 million-$10.20-$8.40-21.43%
2017-06-302017-08-10$3.04 million-$7.73
2014-09-302014-11-06$962451-$24.00-$7.50-220%
2014-06-302014-08-04$3.66 million-$3.00-$16.5081.82%
2014-03-312014-05-08$3.74 million-$12.00-$18.0033.33%
2013-12-312014-03-11$3.65 million-$24.00-$15.00-60%
2013-09-302013-11-07$3.49 million-$24.00-$10.50-128.57%
2013-06-302013-08-07$4.3 million-$6.00-$9.0033.33%
2013-03-312013-05-08$6.48 million-$12.00-$15.0020%
2012-12-312013-03-13$6.01 million-$6.00-$12.0050%
2012-09-302012-11-06$6.7 million-$1.33-$9.0085.25%
2012-06-302012-08-07$6.32 million-$6.00-$9.0033.33%
2012-03-312012-05-08$6.15 million-$18.00-$15.00-20%
2011-12-312012-03-08$3.00-$32.00109.38%
2011-09-302011-11-09$5.26 million-$0.21-$25.0099.17%
2011-06-302011-08-10$6.43 million-$15.00-$31.5052.38%
2011-03-312011-05-11-$12.00-$29.0058.62%
2010-12-312011-03-28-$138.00-$26.00-430.77%
2010-09-302010-11-11-$42.00-$52.0019.23%
2010-06-302010-08-12-$66.00-$61.50-7.32%
2010-03-312010-05-11-$84.00-$51.00-64.71%
2009-12-312010-03-23-$60.00-$61.502.44%
2009-09-302009-11-12-$150.00-$57.00-163.16%
2009-06-302009-08-13-$72.00-$54.00-33.33%
2009-03-312009-05-15-$69.00-$60.00-15%
2008-12-312009-03-30-$51.00-$78.0034.62%
2008-09-302008-11-13-$60.00-$78.0023.08%
2008-06-302008-08-13-$296.82
2008-03-312008-05-14-$68.15
2007-09-302007-11-13-$20.56
2007-03-312007-03-31$7.48
2006-12-312006-12-31-$11,895.61
2006-09-302006-09-30$6.64
2006-06-302006-06-30$6.11
2006-03-312006-03-31$4.47
2005-12-312005-12-31$4.81

Altimmune, Inc (ALT) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Altimmune, Inc (ALT) Chart:

Altimmune, Inc (ALT) News:

Below you will find a list of latest news for Altimmune, Inc (ALT) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Altimmune, Inc (ALT) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-08-2812.12CALL9 241497.09TRUE0.10.05
2026-08-2821.2CALL1 0234.66TRUE1.20
2026-08-2830.24CALL0 25122.97TRUE00
2026-08-2840CALL0 470318.4FALSE00
2026-08-2850CALL0 6265.24FALSE00
2026-08-2860CALL0 15196.83FALSE00
2026-08-2810.05PUT0 52877.21FALSE00
2026-08-2820PUT0 14297.91FALSE00
2026-08-2830.2PUT1 35117.27FALSE0.20
2026-08-2840PUT0 066.9TRUE00
2026-08-2850PUT0 0200.48TRUE00
2026-08-2860PUT0 0374.66TRUE00
2026-09-0412.05CALL4 106490.32TRUE0.070.04
2026-09-0421CALL4 81273.02TRUE0.040.04
2026-09-0430.3CALL1 0172.49TRUE0.30
2026-09-0440.05CALL0 77181.37FALSE00
2026-09-0450CALL0 0275FALSE00
2026-09-0460CALL0 0379.3FALSE00
2026-09-0410.05PUT0 380FALSE00
2026-09-0420PUT0 0253.37FALSE00
2026-09-0430PUT0 0170.36FALSE00
2026-09-0440PUT0 0196.5TRUE00
2026-09-0450PUT0 0204.81TRUE00
2026-09-0460PUT0 0134.59TRUE00
2026-09-1110CALL0 74489.07TRUE00
2026-09-1120CALL0 0334.44TRUE00
2026-09-1130.48CALL2 2178.25TRUE0.480
2026-09-1140.11CALL1 0124.62FALSE0.110
2026-09-1150CALL0 0292.95FALSE00
2026-09-1160CALL0 0357.1FALSE00
2026-09-1110PUT0 0305.01FALSE00
2026-09-1120PUT0 0107.66FALSE00
2026-09-1130PUT0 078.17FALSE00
2026-09-1140PUT0 070.55TRUE00
2026-09-1150PUT0 077.54TRUE00
2026-09-1160PUT0 0113.52TRUE00
2026-09-180.52.6CALL4 202688.28TRUE0.170.07
2026-09-1812.1CALL52 46422.06TRUE2.10
2026-09-181.50CALL0 0241.12TRUE00
2026-09-1820CALL0 511203.01TRUE00
2026-09-182.50.64CALL0 267130.11TRUE00
2026-09-1830.35CALL3 3517121.52TRUE0.040.13
2026-09-183.50.18CALL0 4568118.44FALSE00
2026-09-1840.14CALL9 3953108.78FALSE0.010.08
2026-09-184.50CALL0 1067166.78FALSE00
2026-09-1850.05CALL37 7077155.38FALSE-0.02-0.29
2026-09-185.50CALL0 458263.75FALSE00
2026-09-1860.05CALL3 2113328.07FALSE0.050
2026-09-1870CALL0 594235.58FALSE00
2026-09-1880CALL0 325190.83FALSE00
2026-09-1890CALL0 157181.84FALSE00
2026-09-18100CALL0 442193.23FALSE00
2026-09-180.50PUT0 3293.83FALSE00
2026-09-1810PUT0 18558.21FALSE00
2026-09-181.50PUT0 7300.47FALSE00
2026-09-1820.05PUT0 20196.38FALSE00
2026-09-182.50.1PUT0 7624FALSE00
2026-09-1830.3PUT40 11260FALSE0.30
2026-09-183.50.57PUT1 110TRUE0.570
2026-09-1840PUT0 2920TRUE00
2026-09-184.50PUT0 100TRUE00
2026-09-1850PUT0 9094.65TRUE00
2026-09-185.50PUT0 0109.11TRUE00
2026-09-1860PUT0 1197.57TRUE00
2026-09-1870PUT0 10TRUE00
2026-09-1880PUT0 0115.9TRUE00
2026-09-1890PUT0 0261.48TRUE00
2026-09-18100PUT0 0171.42TRUE00
2026-12-180.50CALL0 1600.96TRUE00
2026-12-1810CALL0 4305.17TRUE00
2026-12-181.50CALL0 0428.86TRUE00
2026-12-1820CALL0 17259.6TRUE00
2026-12-182.50CALL0 40205.98TRUE00
2026-12-1830.65CALL2 515171.72TRUE0.650
2026-12-183.50.43CALL0 89152.24FALSE00
2026-12-1840.4CALL1 944179.82FALSE0.080.25
2026-12-184.50CALL0 23208.25FALSE00
2026-12-1850.25CALL0 899147.13FALSE00
2026-12-185.50CALL0 34200FALSE00
2026-12-1860.12CALL1 449143.88FALSE0.120
2026-12-180.50PUT0 1141.34FALSE00
2026-12-1810PUT0 068.96FALSE00
2026-12-181.50PUT0 5155.3FALSE00
2026-12-1820PUT0 840FALSE00
2026-12-182.50PUT0 330FALSE00
2026-12-1830.5PUT20 3640FALSE0.50
2026-12-183.50PUT0 150TRUE00
2026-12-1840PUT0 540TRUE00
2026-12-184.50PUT0 00TRUE00
2026-12-1850PUT0 00TRUE00
2026-12-185.50PUT0 088.51TRUE00
2026-12-1860PUT0 60TRUE00
2027-01-150.52.55CALL119 4508.93TRUE2.550
2027-01-1512.2CALL4 183422.45TRUE2.20
2027-01-151.50CALL0 101286.83TRUE00
2027-01-1521.17CALL0 6787253.69TRUE00
2027-01-152.50CALL0 130180.4TRUE00
2027-01-1530.7CALL100 5324168.16TRUE0.010.01
2027-01-153.50.5CALL48 3532134.93FALSE00
2027-01-1540.4CALL0 6641160.93FALSE00
2027-01-154.50CALL0 95159.42FALSE00
2027-01-1550.25CALL0 10534164.75FALSE00
2027-01-155.50CALL0 326139.33FALSE00
2027-01-1560CALL0 164170.49FALSE00
2027-01-1570.15CALL0 5679158.38FALSE00
2027-01-15100.1CALL70 10019175.94FALSE00
2027-01-15120.1CALL1 1392179.03FALSE0.10
2027-01-15150CALL0 1885209.2FALSE00
2027-01-15170CALL0 2850216.67FALSE00
2027-01-15200.06CALL1 17600233.7FALSE-0.04-0.4
2027-01-150.50PUT0 2120.76FALSE00
2027-01-1510PUT0 68238.64FALSE00
2027-01-151.50PUT0 192.76FALSE00
2027-01-1520PUT0 3760FALSE00
2027-01-152.50PUT0 3360FALSE00
2027-01-1530PUT0 7400FALSE00
2027-01-153.50PUT0 00TRUE00
2027-01-1541.41PUT0 13300TRUE00
2027-01-154.50PUT0 00TRUE00
2027-01-1550PUT0 13340TRUE00
2027-01-155.50PUT0 00TRUE00
2027-01-1560PUT0 00TRUE00
2027-01-1570PUT0 5600TRUE00
2027-01-15100PUT0 324118.84TRUE00
2027-01-15120PUT0 210TRUE00
2027-01-15150PUT0 1125.24TRUE00
2027-01-15170PUT0 0139.52TRUE00
2027-01-15200PUT0 0144.86TRUE00
2027-03-190.50CALL0 00TRUE00
2027-03-1912.25CALL4 0639.59TRUE2.250
2027-03-191.50CALL0 0356.88TRUE00
2027-03-1920CALL0 0302.41TRUE00
2027-03-192.50CALL0 0263.15TRUE00
2027-03-1930.9CALL8 97201.22TRUE0.90
2027-03-193.50CALL0 0211.65FALSE00
2027-03-1940CALL0 2305160.68FALSE00
2027-03-194.50CALL0 0189.85FALSE00
2027-03-1950CALL0 20212.71FALSE00
2027-03-195.50CALL0 0269.96FALSE00
2027-03-1960CALL0 0223.93FALSE00
2027-03-190.50PUT0 50086.72FALSE00
2027-03-1910PUT0 0181.3FALSE00
2027-03-191.50PUT0 099.08FALSE00
2027-03-1920.25PUT2 120FALSE0.250
2027-03-192.50PUT0 00FALSE00
2027-03-1930PUT0 00FALSE00
2027-03-193.50PUT0 00TRUE00
2027-03-1940PUT0 00TRUE00
2027-03-194.50PUT0 00TRUE00
2027-03-1950PUT0 00TRUE00
2027-03-195.50PUT0 084.45TRUE00
2027-03-1960PUT0 092.24TRUE00
2028-01-210.52.75CALL394 1881106.01TRUE2.750
2028-01-2112.3CALL121 147481.53TRUE2.30
2028-01-211.50CALL0 34783.37TRUE00
2028-01-2120CALL0 1640TRUE00
2028-01-212.50CALL0 19307.83TRUE00
2028-01-2131.35CALL83 16668298.26TRUE0.050.04
2028-01-213.51.16CALL0 97316.69FALSE00
2028-01-2141.14CALL12 933275.03FALSE0.180.19
2028-01-214.50.96CALL18 994284.64FALSE0.050.05
2028-01-2150.97CALL28 958263.24FALSE0.10.11
2028-01-215.50.89CALL22 121353.3FALSE0.890
2028-01-2170CALL0 2450239.56FALSE00
2028-01-21100.43CALL0 8167243.24FALSE00
2028-01-210.50PUT0 340FALSE00
2028-01-2110PUT0 130FALSE00
2028-01-211.50PUT0 20FALSE00
2028-01-2120PUT0 110FALSE00
2028-01-212.50PUT0 00FALSE00
2028-01-2130PUT0 260FALSE00
2028-01-213.50PUT0 081.86TRUE00
2028-01-2141.92PUT0 1777.8TRUE00
2028-01-214.50PUT0 4369.63TRUE00
2028-01-2150PUT0 4394.76TRUE00
2028-01-215.50PUT0 00TRUE00
2028-01-2170PUT0 420TRUE00
2028-01-21100PUT0 1030TRUE00

Latest ALT Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST1$9.25
Jun 13, 2022 7:59 PM EST399$9.25
Jun 13, 2022 7:59 PM EST58$9.25
Jun 13, 2022 7:59 PM EST100$9.25
Jun 13, 2022 7:59 PM EST200$9.235

Altimmune, Inc (ALT) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320018161/0000899243-20-018161-index.htm
2019-04-15UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1326190/000000000019007165/0000000000-19-007165-index.htm
2019-08-16UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1326190/000000000019012559/0000000000-19-012559-index.htm
2019-08-22UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1326190/000000000019012749/0000000000-19-012749-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924319016650/0000899243-19-016650-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924319017407/0000899243-19-017407-index.htm
2019-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924319022846/0000899243-19-022846-index.htm
2019-09-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924319023316/0000899243-19-023316-index.htm
2019-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924319023318/0000899243-19-023318-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924319028409/0000899243-19-028409-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320000074/0000899243-20-000074-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320000275/0000899243-20-000275-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320000276/0000899243-20-000276-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320000279/0000899243-20-000279-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320000286/0000899243-20-000286-index.htm
2020-02-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320002630/0000899243-20-002630-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320002960/0000899243-20-002960-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320002986/0000899243-20-002986-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320003006/0000899243-20-003006-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320006772/0000899243-20-006772-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320009897/0000899243-20-009897-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320011911/0000899243-20-011911-index.htm
2020-05-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320012836/0000899243-20-012836-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320012840/0000899243-20-012840-index.htm
2020-05-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320013395/0000899243-20-013395-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320014937/0000899243-20-014937-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320017823/0000899243-20-017823-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320017824/0000899243-20-017824-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320017826/0000899243-20-017826-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320017831/0000899243-20-017831-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320017833/0000899243-20-017833-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320017835/0000899243-20-017835-index.htm
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320018161/0000899243-20-018161-index.htm
2020-08-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320021020/0000899243-20-021020-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320021205/0000899243-20-021205-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320021207/0000899243-20-021207-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320021212/0000899243-20-021212-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320021219/0000899243-20-021219-index.htm
2020-08-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320023683/0000899243-20-023683-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026409/0000899243-20-026409-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026410/0000899243-20-026410-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026411/0000899243-20-026411-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026412/0000899243-20-026412-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026413/0000899243-20-026413-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026414/0000899243-20-026414-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026415/0000899243-20-026415-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320026921/0000899243-20-026921-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320028535/0000899243-20-028535-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320028536/0000899243-20-028536-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320028537/0000899243-20-028537-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320028538/0000899243-20-028538-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320028539/0000899243-20-028539-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320028540/0000899243-20-028540-index.htm
2020-11-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000089924320030113/0000899243-20-030113-index.htm
2019-03-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000092542119000135/0000925421-19-000135-index.htm
2019-03-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000092542119000137/0000925421-19-000137-index.htm
2018-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297518001065/0001012975-18-001065-index.htm
2018-10-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297518001091/0001012975-18-001091-index.htm
2018-10-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297518001100/0001012975-18-001100-index.htm
2018-12-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297518001271/0001012975-18-001271-index.htm
2018-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297518001273/0001012975-18-001273-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000028/0001012975-19-000028-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000029/0001012975-19-000029-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000031/0001012975-19-000031-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000033/0001012975-19-000033-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000035/0001012975-19-000035-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000037/0001012975-19-000037-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000039/0001012975-19-000039-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000041/0001012975-19-000041-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000101297519000043/0001012975-19-000043-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000106823820000055/0001068238-20-000055-index.htm
2018-10-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000110465918060692/0001104659-18-060692-index.htm
2019-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000110465919005825/0001104659-19-005825-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000110465919008563/0001104659-19-008563-index.htm
2020-06-01SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000110465920068336/0001104659-20-068336-index.htm
2020-06-25SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1326190/000110465920076855/0001104659-20-076855-index.htm
2020-09-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000110465920108310/0001104659-20-108310-index.htm
2020-10-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000110465920112175/0001104659-20-112175-index.htm
2018-09-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518280602/0001193125-18-280602-index.htm
2018-09-24424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312518280966/0001193125-18-280966-index.htm
2018-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518281668/0001193125-18-281668-index.htm
2018-09-26S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1326190/000119312518284095/0001193125-18-284095-index.htm
2018-09-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1326190/000119312518285764/0001193125-18-285764-index.htm
2018-09-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1326190/000119312518285783/0001193125-18-285783-index.htm
2018-09-28POS EXPost-effective amendment adding exhibits to registration statement [Rule 462(d)]https://www.sec.gov/Archives/edgar/data/1326190/000119312518286447/0001193125-18-286447-index.htm
2018-10-01424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1326190/000119312518289729/0001193125-18-289729-index.htm
2018-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518289763/0001193125-18-289763-index.htm
2018-10-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000119312518293265/0001193125-18-293265-index.htm
2018-10-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518295412/0001193125-18-295412-index.htm
2018-10-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312518295424/0001193125-18-295424-index.htm
2018-10-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312518296082/0001193125-18-296082-index.htm
2018-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518304261/0001193125-18-304261-index.htm
2018-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518325584/0001193125-18-325584-index.htm
2018-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326190/000119312518325587/0001193125-18-325587-index.htm
2018-11-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518335258/0001193125-18-335258-index.htm
2018-11-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518339667/0001193125-18-339667-index.htm
2018-11-30S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1326190/000119312518339756/0001193125-18-339756-index.htm
2018-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312518340078/0001193125-18-340078-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000119312519033928/0001193125-19-033928-index.htm
2019-03-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519067835/0001193125-19-067835-index.htm
2019-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519070141/0001193125-19-070141-index.htm
2019-03-11424B2Prospectus [Rule 424(b)(2)]https://www.sec.gov/Archives/edgar/data/1326190/000119312519070146/0001193125-19-070146-index.htm
2019-03-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519076851/0001193125-19-076851-index.htm
2019-04-04S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1326190/000119312519097986/0001193125-19-097986-index.htm
2019-04-04S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1326190/000119312519097996/0001193125-19-097996-index.htm
2019-04-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1326190/000119312519103831/0001193125-19-103831-index.htm
2019-04-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1326190/000119312519104131/0001193125-19-104131-index.htm
2019-06-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519168149/0001193125-19-168149-index.htm
2019-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519171212/0001193125-19-171212-index.htm
2019-06-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519178904/0001193125-19-178904-index.htm
2019-07-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519190926/0001193125-19-190926-index.htm
2019-07-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519193586/0001193125-19-193586-index.htm
2019-08-09PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1326190/000119312519218069/0001193125-19-218069-index.htm
2019-08-14S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1326190/000119312519221188/0001193125-19-221188-index.htm
2019-08-19CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1326190/000119312519224352/0001193125-19-224352-index.htm
2019-08-19PRER14APreliminary Proxy Soliciting materialshttps://www.sec.gov/Archives/edgar/data/1326190/000119312519224357/0001193125-19-224357-index.htm
2019-08-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519225595/0001193125-19-225595-index.htm
2019-08-22DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1326190/000119312519226618/0001193125-19-226618-index.htm
2019-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312519259847/0001193125-19-259847-index.htm
2020-03-27424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312520087649/0001193125-20-087649-index.htm
2020-03-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520088680/0001193125-20-088680-index.htm
2020-04-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520100902/0001193125-20-100902-index.htm
2020-05-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520139801/0001193125-20-139801-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520156447/0001193125-20-156447-index.htm
2020-06-01424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312520156472/0001193125-20-156472-index.htm
2020-07-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520191485/0001193125-20-191485-index.htm
2020-07-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312520191866/0001193125-20-191866-index.htm
2020-07-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326190/000119312520192791/0001193125-20-192791-index.htm
2020-07-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520194024/0001193125-20-194024-index.htm
2020-07-168-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520194052/0001193125-20-194052-index.htm
2020-08-21DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1326190/000119312520226963/0001193125-20-226963-index.htm
2020-08-21S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1326190/000119312520226971/0001193125-20-226971-index.htm
2020-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000119312520254566/0001193125-20-254566-index.htm
2020-02-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000120919120009672/0001209191-20-009672-index.htm
2018-10-17SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000121390018014006/0001213900-18-014006-index.htm
2019-02-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000121390019001904/0001213900-19-001904-index.htm
2020-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000121390020003212/0001213900-20-003212-index.htm
2019-02-01SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000139382519000035/0001393825-19-000035-index.htm
2020-01-31SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326190/000139382520000012/0001393825-20-000012-index.htm
2019-04-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1326190/000156459019010429/0001564590-19-010429-index.htm
2019-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459019010435/0001564590-19-010435-index.htm
2019-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326190/000156459019019139/0001564590-19-019139-index.htm
2019-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459019019146/0001564590-19-019146-index.htm
2019-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326190/000156459019031795/0001564590-19-031795-index.htm
2019-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459019031811/0001564590-19-031811-index.htm
2019-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326190/000156459019043231/0001564590-19-043231-index.htm
2019-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459019043240/0001564590-19-043240-index.htm
2020-03-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459020013376/0001564590-20-013376-index.htm
2020-03-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1326190/000156459020013377/0001564590-20-013377-index.htm
2020-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326190/000156459020025123/0001564590-20-025123-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459020025137/0001564590-20-025137-index.htm
2020-08-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326190/000156459020039298/0001564590-20-039298-index.htm
2020-08-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326190/000156459020039314/0001564590-20-039314-index.htm
2020-05-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000173804820000001/0001738048-20-000001-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326190/000173804820000003/0001738048-20-000003-index.htm
2018-09-27EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1326190/999999999518002478/9999999995-18-002478-index.htm
2019-04-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1326190/999999999519000701/9999999995-19-000701-index.htm
2018-10-04CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1326190/999999999718008376/9999999997-18-008376-index.htm

Altimmune, Inc (ALT) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Altimmune, Inc (ALT). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 651%
Institutional Ownership: 6730%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-07-31William Michael BrownChief Financial OfficerBuy7,920.001.4611,563.2015,981.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320021212/0000899243-20-021212-index.htm
2020-05-15VELOCITY PHARMACEUTICAL HOLDINGS LLC10% Share HolderSell30,622.004.65142,392.301,687,250.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320013395/0000899243-20-013395-index.htm
2020-05-14VELOCITY PHARMACEUTICAL HOLDINGS LLC10% Share HolderSell169,378.004.81814,708.181,717,872.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320013395/0000899243-20-013395-index.htm
2018-10-09Wayne PisanoDirectorBuy2,000.004.599,180.002,000.00https://www.sec.gov/Archives/edgar/data/1326190/000101297518001100/0001012975-18-001100-index.htm
2020-05-26Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy309,453.008.792,720,091.872,005,817.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2020-05-26Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy390,547.009.783,819,549.662,396,364.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2020-05-27Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy125,162.007.23904,921.262,521,526.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2020-05-27Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy277,000.007.922,193,840.002,798,526.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2020-05-28Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy27,763.007.79216,273.772,826,289.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2020-05-28Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy173,711.008.871,540,816.573,000,000.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000002/0001738048-20-000002-index.htm
2018-11-30Vipin K GargPresident and CEOBuy322,907.00322,907.00https://www.sec.gov/Archives/edgar/data/1326190/000101297518001273/0001012975-18-001273-index.htm
2020-07-31Vipin K GargChief Financial OfficerBuy11,674.001.4617,044.04325,789.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320021205/0000899243-20-021205-index.htm
2020-01-31Vipin K GargPresident and CEOBuy11,289.001.4616,481.94326,206.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320002986/0000899243-20-002986-index.htm
2019-09-05Vipin K GargPresident and CEOBuy20,000.002.1042,000.00342,907.00https://www.sec.gov/Archives/edgar/data/1326190/000089924319022846/0000899243-19-022846-index.htm
2020-06-15Venrock Healthcare Capital Partners III, L.P.10% Share HolderBuy1,500,000.007.5411,310,000.004,500,000.00https://www.sec.gov/Archives/edgar/data/1326190/000173804820000003/0001738048-20-000003-index.htm
2020-01-31M Scot RobertsChief Scientific OfficerBuy3,698.001.465,399.085,535.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320002960/0000899243-20-002960-index.htm
2020-01-31William Michael BrownChief Financial OfficerBuy8,061.001.4611,769.068,061.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320003006/0000899243-20-003006-index.htm
2020-07-31Matthew Scott HarrisChief Medical OfficerBuy8,084.001.4611,802.648,084.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320021219/0000899243-20-021219-index.htm
2020-07-31M Scot RobertsChief Scientific OfficerBuy3,859.001.465,634.149,394.00https://www.sec.gov/Archives/edgar/data/1326190/000089924320021207/0000899243-20-021207-index.htm